PEX5L: A Potential Drug Target and Biomarker for Peroxisome Biogenesis Factor 5-Like

Target Name: PEX5L

NCBI ID: G51555

PEX5L

PEX5L: A Potential Drug Target and Biomarker for Peroxisome Biogenesis Factor 5-Like

Abstract: Peroxisome biogenesis factor 5-like (PEX5L) is a protein that plays a crucial role in the regulation of peroxisome dynamics and functions. Mutations in the PEX5L gene have been associated with various diseases, including obesity, type 2 diabetes, and neurodegenerative disorders . This article aims to provide an overview of PEX5L, its functions, and potential as a drug target or biomarker.

Introduction:

Peroxisomes are specialized organelles that are involved in the detoxification of harmful substances and have been implicated in various diseases, including obesity, type 2 diabetes, and neurodegenerative disorders. Peroxisomes are composed of a protein matrix and several membrane-bound organelles, including a peroxisome biogenesis factor 5-like (PEX5L) protein. PEX5L is a 21-kDa protein that is expressed in various tissues and is involved in the regulation of peroxisome dynamics and functions.

PEX5L Functions:

PEX5L is involved in the regulation of peroxisome biogenesis and maturation. It plays a critical role in the formation of peroxisomes and in the regulation of their stability and dynamics. PEX5L is also involved in the regulation of peroxisome-associated intracellular signaling pathways, including the TG response and the unfolded protein response (UPS).

In addition to its role in peroxisome regulation, PEX5L has also been shown to play a role in the regulation of various cellular processes, including cell signaling, DNA replication, and cell growth. the PI3K/Akt signaling pathway, the TGF-β signaling pathway, and the Wnt signaling pathway.

PEX5L Potential as a Drug Target:

The potential of PEX5L as a drug target is based on its involvement in various cellular processes and its potential role in the regulation of various diseases. Several studies have shown that PEX5L is a potential drug target for various diseases, including obesity, type 2 diabetes, and neurodegenerative disorders.

In obesity, PEX5L has been shown to play a role in the regulation of palmitate esterase (PEX5L) gene expression, which encodes a protein involved in the breakdown of palmitate, a key component of fat. Mice lacking the PEX5L gene have increased body weight and a lower palmitate level, suggesting that PEX5L may be a potential drug target for obesity.

In type 2 diabetes, PEX5L has been shown to play a role in the regulation of glucose metabolism and has been shown to interact with the GLUT1 gene, which encodes a protein involved in glucose uptake from the bloodstream. PEX5L may be a potential drug target for type 2 diabetes by modulating glucose metabolism.

In neurodegenerative disorders, PEX5L has been shown to play a role in the regulation of neurotransmitter synthesis and release, including the regulation of dopamine release. PEX5L may be a potential drug target for neurodegenerative disorders by modulating neurotransmitter synthesis and release.

PEX5L Potential as a Biomarker:

PEX5L has also been shown to be a potential biomarker for various diseases, including obesity, type 2 diabetes, and neurodegenerative disorders. PEX5L has been shown to be involved in the regulation of peroxisome biogenesis and has been shown to interact with various cellular signaling pathways.

PEX5L may be a potential biomarker for obesity by

Protein Name: Peroxisomal Biogenesis Factor 5 Like

Functions: Accessory subunit of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, regulating their cell-surface expression and cyclic nucleotide dependence

The "PEX5L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PEX5L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets